ESRRA and neoplasm: Accordingly, the absence of ERRα is able to impair tumorigenic potential in aggressive xenografted breast cancer cells where the ERRα/PGC-1α complex binds to a VEGF promoter region regulating its expression, and promoting tumor angiogenesis and invasion.